Cargando…

Angiotensin Converting Enzyme Inhibition Reduces Cardiovascular Responses to Acute Stress in Myocardially Infarcted and Chronically Stressed Rats

Previous studies showed that chronically stressed and myocardially infarcted rats respond with exaggerated cardiovascular responses to acute stress. The present experiments were designed to elucidate whether this effect can be abolished by treatment with the angiotensin converting enzyme (ACE) inhib...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cudnoch-Jedrzejewska, A., Czarzasta, K., Puchalska, L., Dobruch, J., Borowik, O., Pachucki, J., Szczepanska-Sadowska, E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4087298/ https://www.ncbi.nlm.nih.gov/pubmed/25045668 http://dx.doi.org/10.1155/2014/385082

Ejemplares similares

Dysregulation of the Renin-Angiotensin System and the Vasopressinergic System Interactions in Cardiovascular Disorders
por: Szczepanska-Sadowska, Ewa, et al.
Publicado: (2018)

Multiple Aspects of Inappropriate Action of Renin–Angiotensin, Vasopressin, and Oxytocin Systems in Neuropsychiatric and Neurodegenerative Diseases
por: Szczepanska-Sadowska, Ewa, et al.
Publicado: (2022)

Interaction of Orexin A and Vasopressin in the Brain Plays a Role in Blood Pressure Regulation in WKY and SHR Rats
por: Kowalewski, Stanisław, et al.
Publicado: (2020)

The Influence of Gut Microbiota on the Cardiovascular System Under Conditions of Obesity and Chronic Stress
por: Dubinski, Piotr, et al.
Publicado: (2021)

Complementary Role of Oxytocin and Vasopressin in Cardiovascular Regulation
por: Szczepanska-Sadowska, Ewa, et al.
Publicado: (2021)

New Peptides as Potential Players in the Crosstalk Between the Brain and Obesity, Metabolic and Cardiovascular Diseases
por: Czerwińska, Magdalena, et al.
Publicado: (2021)

Sphingolipids in cardiovascular diseases and metabolic disorders
por: Borodzicz, Sonia, et al.
Publicado: (2015)

A Review of the Roles of Apelin and ELABELA Peptide Ligands in Cardiovascular Disease, Including Heart Failure and Hypertension
por: Rozwadowski, Jan, et al.
Publicado: (2022)

Sphingolipid metabolism and signaling in cardiovascular diseases
por: Borodzicz-Jażdżyk, Sonia, et al.
Publicado: (2022)

Common Genetic Variants Link the Abnormalities in the Gut-Brain Axis in Prematurity and Autism
por: Sajdel-Sulkowska, Elżbieta M., et al.
Publicado: (2018)

Remodeling and Fibrosis of the Cardiac Muscle in the Course of Obesity—Pathogenesis and Involvement of the Extracellular Matrix
por: Kruszewska, Jagoda, et al.
Publicado: (2022)

Communication of gut microbiota and brain via immune and neuroendocrine signaling
por: Kasarello, Kaja, et al.
Publicado: (2023)

Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Prothrombotic Processes and Myocardial Infarction Risk
por: Dézsi, Csaba András, et al.
Publicado: (2016)

Angiotensin-converting-enzyme inhibitor prevents skeletal muscle fibrosis in myocardial infarction mice
por: Kakutani, Naoya, et al.
Publicado: (2020)

Effect of Chronic Kidney Disease on Changes in Vasopressin System Expression in the Kidney Cortex in Rats with Nephrectomy
por: Czarzasta, Katarzyna, et al.
Publicado: (2018)

Vasopressin and Breathing: Review of Evidence for Respiratory Effects of the Antidiuretic Hormone
por: Proczka, Michał, et al.
Publicado: (2021)

Comparison of clinical outcomes of angiotensin receptor blockers with angiotensin-converting enzyme inhibitors in patients with acute myocardial infarction
por: Chen, Chih-Wei, et al.
Publicado: (2023)

Authors’ response to the letter: Takotsubo syndrome: a neurocardiac syndrome inside the autonomic nervous system
por: Borodzicz, Sonia, et al.
Publicado: (2019)

Inflammatory Forms of Cardiomyocyte Cell Death in the Rat Model of Isoprenaline-Induced Takotsubo Syndrome
por: Borodzicz-Jażdżyk, Sonia, et al.
Publicado: (2023)

Angiotensin Converting Enzymes
por: Wong, Marty K.S.
Publicado: (2016)

Angiotensin converting enzyme
por: Wong, Marty Kwok-Shing
Publicado: (2021)

Angiotensin Receptor Blockers as an Alternative to Angiotensin-Converting Enzyme Inhibitors in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention
por: Lim, Sungmin, et al.
Publicado: (2019)

Impact of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers on clinical outcomes in hypertensive patients with acute myocardial infarction
por: Lee, Jae-Geun, et al.
Publicado: (2023)

Angiotensin-Converting Enzyme-2
por: Clarke, Nicola E., et al.
Publicado: (2013)

Tenascin‐C aggravates ventricular dilatation and angiotensin‐converting enzyme activity after myocardial infarction in mice
por: Santer, David, et al.
Publicado: (2020)

Editorial: New Trends in the Renin-Angiotensin-Aldosterone System in Cardiovascular Disease
por: Szczepanska-Sadowska, Ewa, et al.
Publicado: (2021)

The Efficacy of Angiotensin Receptor-Neprilysin Inhibitor Versus Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Post Myocardial Infarction: A Meta-Analysis
por: Kotak, Sohny, et al.
Publicado: (2023)

Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)

Angiotensin-Converting Enzyme 2: Central Regulator for Cardiovascular Function
por: Xia, Huijing, et al.
Publicado: (2010)

Comparison of Outcomes Between Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Patients With Myocardial Infarction: A Meta-Analysis
por: Escobar, Johao, et al.
Publicado: (2023)

Angiotensin-Converting Enzyme Inhibitor-Induced Oropharyngeal edema with Subsequent Stress-Cardiomyopathy
por: Cronin, Michael, et al.
Publicado: (2021)

Regulation of Cardiovascular Control Mechanisms by Angiotensin-(1–7) and Angiotensin-Converting Enzyme 2
por: Ferrario, Carlos M., et al.
Publicado: (2010)

Effect of renin angiotensin blockers on angiotensin converting enzyme 2 level in cardiovascular patients
por: Farid fahmy, Sarah, et al.
Publicado: (2023)

Angiotensin-converting enzyme activity and inhibition in dogs with cardiac disease and an angiotensin-converting enzyme polymorphism
por: Meurs, Kathryn M, et al.
Publicado: (2017)

Dietary Potassium Downregulates Angiotensin-I Converting Enzyme, Renin, and Angiotensin Converting Enzyme 2
por: Vio, Carlos P., et al.
Publicado: (2020)

Evaluation of Nitrosative/Oxidative Stress and Inflammation in Heart Failure with Preserved and Reduced Ejection Fraction
por: Momot, Karol, et al.
Publicado: (2023)

In reply—Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)

Effect of angiotensin‐converting enzyme inhibition on cardiovascular adaptation to exercise training
por: Sjúrðarson, Tórur, et al.
Publicado: (2022)

How long should angiotensin-converting enzyme inhibitors be given to patients following myocardial infarction: implications of the HOPE trial
por: Bonarjee, Vernon VS, et al.
Publicado: (2001)

Role of Angiotensin-Converting Enzyme (ACE) gene polymorphism and ACE activity in predicting outcome after acute myocardial infarction
por: Moorthy, Nagaraja, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_51qih89opgis1rc8u96ql4ilnl